CAR-T cell therapy in Multiple Myeloma: current status and future challenges
D Swan, D Madduri, J Hocking - Blood Cancer Journal, 2024 - nature.com
The treatment of multiple myeloma has changed dramatically in recent years, with huge
strides forward made in the field. Chimeric antigen receptor T-cell therapy targeting the B …
strides forward made in the field. Chimeric antigen receptor T-cell therapy targeting the B …
Charting the Course: Sequencing Immunotherapy for Multiple Myeloma
Multiple chimeric antigen receptor (CAR) T-cell and bispecific antibody (bsAb) therapies
have been approved, demonstrating impressive clinical efficacy in relapsed/refractory …
have been approved, demonstrating impressive clinical efficacy in relapsed/refractory …
Immune prognostic score predicts the risk of infection and survival outcomes in patients with relapsed multiple myeloma treated with bispecific antibodies
The Glasgow prognostic score (GPS) and CAR‐HEMATOTOX (CAR‐HT) score identify
multiple myeloma (MM) patients at high risk for immune‐mediated toxicity and early mortality …
multiple myeloma (MM) patients at high risk for immune‐mediated toxicity and early mortality …
Incidence of Acute Kidney Injury in Relapsed and Refractory Multiple Myeloma treated with Teclistamab versus CAR T-cells
M Charkviani, MJV Brochero, A Mohan… - Nephrology Dialysis …, 2025 - academic.oup.com
Abstract Background and Hypothesis Teclistamab, a novel bispecific monoclonal antibody
targeting CD3 and B-cell maturation antigen (BCMA), and chimeric antigen receptor T-cell …
targeting CD3 and B-cell maturation antigen (BCMA), and chimeric antigen receptor T-cell …
Myeloma CAR T-cell therapy toxicity timing: What is the right amount of post-treatment monitoring for our patients?
JN Brudno - … and Cellular Therapy, Official Publication of the …, 2024 - astctjournal.org
One additional non-relapse death occurring between 30 and 90 days after cell infusion was
attributed to infection. All deaths in the first 30 days occurred during the initial admission …
attributed to infection. All deaths in the first 30 days occurred during the initial admission …